News in the Life Sciences Industry

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- Newly published results from three independent research groups support the concept behind Sprint Biosciences' drug project Vps34. The articles confirm that autophagy in tumors makes it easier for cancer cells to escape attacks from the body's immune... Read more ››

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), a world-leading provider of replication solutions allowing endovascular procedures to be performed by doctors... Read more ››

OSLO, Norway, Oct. 1, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces the commencement of the sales, marketing and distribution of Hexvix(®) in the European markets formerly operated by Ipsen Pharma SAS (Ipsen). The successful transition and launch of European Hexvix... Read more ››

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) announced today that the open-label Expanded Access Program, Read more ››

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- SyntheticMR announced today that they have signed an agreement with GE Healthcare to integrate their quantitative MRI solution SyMRI in GE's platform. As part of the agreement, GE Healthcare will integrate the new SyMRI offering into their platform... Read more ››

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the U.S. Food and Drug Administration (FDA) has accepted IRLAB's investigational new drug application (IND) for the drug candidate mesdopetam (IRL790). The acceptance of the IND will allow... Read more ››

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the last visit of the 200(th) patient has taken place in Part A of the pivotal NeflgArd Phase 3 study